Market size in innovation: theory and evidence from the pharmaceutical industry
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2003
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
10038 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 40, [17] S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023590681 | ||
| 003 | DE-604 | ||
| 005 | 20091113 | ||
| 007 | t | ||
| 008 | 040617s2003 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)53343504 | ||
| 035 | |a (DE-599)BVBBV023590681 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HD9665.5 | |
| 082 | 0 | |a 330.072 | |
| 100 | 1 | |a Acemoglu, Daron |d 1967- |e Verfasser |0 (DE-588)124929575 |4 aut | |
| 245 | 1 | 0 | |a Market size in innovation |b theory and evidence from the pharmaceutical industry |c Daron Acemoglu ; Joshua Linn |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2003 | |
| 300 | |a 40, [17] S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 10038 | |
| 650 | 4 | |a Demography |z United States | |
| 650 | 4 | |a Drug Industry |x economics |z United States | |
| 650 | 4 | |a Economies of scale | |
| 650 | 4 | |a Marketing |x economics |z United States | |
| 650 | 4 | |a Pharmaceutical industry |x Technological innovations | |
| 650 | 4 | |a Technology, Pharmaceutical |x trends |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Linn, Joshua |e Verfasser |0 (DE-588)131608681 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 10038 |w (DE-604)BV002801238 |9 10038 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w10038.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016906011 | ||
Datensatz im Suchindex
| _version_ | 1804138247075397632 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Acemoglu, Daron 1967- Linn, Joshua |
| author_GND | (DE-588)124929575 (DE-588)131608681 |
| author_facet | Acemoglu, Daron 1967- Linn, Joshua |
| author_role | aut aut |
| author_sort | Acemoglu, Daron 1967- |
| author_variant | d a da j l jl |
| building | Verbundindex |
| bvnumber | BV023590681 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9665 |
| callnumber-raw | HD9665.5 |
| callnumber-search | HD9665.5 |
| callnumber-sort | HD 49665.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| ctrlnum | (OCoLC)53343504 (DE-599)BVBBV023590681 |
| dewey-full | 330.072 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 330 - Economics |
| dewey-raw | 330.072 |
| dewey-search | 330.072 |
| dewey-sort | 3330.072 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01626nam a2200421zcb4500</leader><controlfield tag="001">BV023590681</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20091113 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">040617s2003 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)53343504</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023590681</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">330.072</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Acemoglu, Daron</subfield><subfield code="d">1967-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)124929575</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Market size in innovation</subfield><subfield code="b">theory and evidence from the pharmaceutical industry</subfield><subfield code="c">Daron Acemoglu ; Joshua Linn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">40, [17] S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">10038</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Demography</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economies of scale</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Technological innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield><subfield code="x">trends</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linn, Joshua</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)131608681</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">10038</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">10038</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w10038.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016906011</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023590681 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:27Z |
| indexdate | 2024-07-09T21:25:09Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016906011 |
| oclc_num | 53343504 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 40, [17] S. graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Acemoglu, Daron 1967- Verfasser (DE-588)124929575 aut Market size in innovation theory and evidence from the pharmaceutical industry Daron Acemoglu ; Joshua Linn Cambridge, Mass. National Bureau of Economic Research 2003 40, [17] S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 10038 Demography United States Drug Industry economics United States Economies of scale Marketing economics United States Pharmaceutical industry Technological innovations Technology, Pharmaceutical trends United States USA Linn, Joshua Verfasser (DE-588)131608681 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 10038 (DE-604)BV002801238 10038 http://papers.nber.org/papers/w10038.pdf kostenfrei Volltext |
| spellingShingle | Acemoglu, Daron 1967- Linn, Joshua Market size in innovation theory and evidence from the pharmaceutical industry National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Demography United States Drug Industry economics United States Economies of scale Marketing economics United States Pharmaceutical industry Technological innovations Technology, Pharmaceutical trends United States |
| title | Market size in innovation theory and evidence from the pharmaceutical industry |
| title_auth | Market size in innovation theory and evidence from the pharmaceutical industry |
| title_exact_search | Market size in innovation theory and evidence from the pharmaceutical industry |
| title_exact_search_txtP | Market size in innovation theory and evidence from the pharmaceutical industry |
| title_full | Market size in innovation theory and evidence from the pharmaceutical industry Daron Acemoglu ; Joshua Linn |
| title_fullStr | Market size in innovation theory and evidence from the pharmaceutical industry Daron Acemoglu ; Joshua Linn |
| title_full_unstemmed | Market size in innovation theory and evidence from the pharmaceutical industry Daron Acemoglu ; Joshua Linn |
| title_short | Market size in innovation |
| title_sort | market size in innovation theory and evidence from the pharmaceutical industry |
| title_sub | theory and evidence from the pharmaceutical industry |
| topic | Demography United States Drug Industry economics United States Economies of scale Marketing economics United States Pharmaceutical industry Technological innovations Technology, Pharmaceutical trends United States |
| topic_facet | Demography United States Drug Industry economics United States Economies of scale Marketing economics United States Pharmaceutical industry Technological innovations Technology, Pharmaceutical trends United States USA |
| url | http://papers.nber.org/papers/w10038.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT acemogludaron marketsizeininnovationtheoryandevidencefromthepharmaceuticalindustry AT linnjoshua marketsizeininnovationtheoryandevidencefromthepharmaceuticalindustry |